Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (6)

2009

  1. Effects of chronic blockade of 5-HT6 receptors on NMDA receptor subunits expression

    Synapse, Vol. 63, Núm. 9, pp. 814-816

2008

  1. Effects of 5-HT 6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat

    British Journal of Pharmacology, Vol. 155, Núm. 3, pp. 434-440

  2. Involvement of an altered 5-HT6 receptor function in behavioral symptoms of Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 14, Núm. 1, pp. 43-50

2006

  1. Lack of localization of 5-HT6 receptors on cholinergic neurons: Implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release

    European Journal of Neuroscience, Vol. 24, Núm. 5, pp. 1299-1306

2004

  1. Differential Involvement of 5-HT1B/1D and 5-HT6 Receptors in Cognitive and Non-cognitive Symptoms in Alzheimer's Disease

    Neuropsychopharmacology, Vol. 29, Núm. 2, pp. 410-416

2003

  1. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration

    Journal of Neurochemistry, Vol. 85, Núm. 6, pp. 1480-1487